Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
A Single-Center, Double-Masked, Randomized, Placebo-Controlled, Parallel-Group Allergen BioCube Study Evaluating the Efficacy and Safety of Nasapaque Nasal Solution in a Population of Adult Subjects With Seasonal Allergic Rhinitis
Single-center, double-masked, randomized, placebo-controlled, parallel-group, efficacy and safety study using the Allergen BioCube (ABC).
100 Clinical Results associated with 3E Therapeutics Corporation
0 Patents (Medical) associated with 3E Therapeutics Corporation
100 Deals associated with 3E Therapeutics Corporation
100 Translational Medicine associated with 3E Therapeutics Corporation